Skip to main content
Equibles

John Hanna

CEO

CareDx, Inc. (CDNA)

Equibles does not estimate personal net worth.

Get an email with a short summary when CareDx, Inc. publishes a filing, an earnings call transcript or a press release.

Get CDNA alerts

About John Hanna

John Hanna is recorded as CEO at CareDx, Inc. (CDNA). The proxy statement of Veracyte, Inc. reports total compensation of $1,785,853 for John Hanna in fiscal 2020, including a base salary of $395,000. Disclosed compensation is on record for 2 fiscal years. John Hanna has spoken on 9 earnings calls and 1 other investor event across 1 company, most recently for CareDx, Inc. on July 30, 2026. CareDx, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at CareDx, Inc. includes Alexander L. Johnson (CEO), John W. Hanna (CEO and Board Member), Michael D. Goldberg (Chairman and Board Member) and 7 others.

John Hanna on recent calls

“Two years ago, we set out to transform CareDx into a leading precision medicine diagnostics company. Today, that transformation is largely complete. We deepened our leadership in transplantation.”
CEO, CareDx Q2’26 Earnings Call ·
“I'm the Chief Executive Officer here at CareDx. Please refer to the Safe Harbor statement on our website related to any forward-looking statements in the presentation today.”
CEO, Jefferies 2026 Global Healthcare Conference ·
“Since I joined CARDIX in 2024, I have been singularly focused on transforming this company into a precision diagnostics market leader.”
CEO, CareDx, Inc. Q1 FY2026 Earnings Call ·
“2025 was a transformative year for CARE DX. We advanced our market leadership across heart, lung, and kidney transplantation with an expanded commercial footprint, including a broader sales and medical presence to execute our solution-selling strategy that drove growth across all business segments.”
CEO, CareDx, Inc. Q4 FY2025 Earnings Call ·
“We had a strong third quarter on many fronts, including record volume and record revenue in testing services, patient and digital solutions, and our lab products businesses.”
CEO, CareDx, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at CareDx, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Veracyte, Inc. (VCYT) $395,000 $1,785,853
2019 Veracyte, Inc. (VCYT) $375,000 $2,030,010

Recent activity